Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
Clinical trial NCT06960382 · RECRUITING
Trial details
- NCT number
- NCT06960382
- Sponsor
- University of Zurich
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-20
- Primary completion
- 2027-05-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.